Medical Journals

Survival Following Relapse in Childhood Haematological Malignancies Diagnosed in 1974-2003 in Yorkshire, Uk.

Authors:
  • Feltbower R G
  • Kinsey S E
  • Richards M
  • Shenton G
  • Michelagnoli M P
  • McKinney P A

From: Paediatric Epidemiology Group, Centre for Epidemiology and Biostatistics, 30-32 Hyde Terrace, University of Leeds, Leeds, UK. r.g.feltbower@leeds.ac.uk

British journal of cancer

  • Publish Date: Apr 2007
  • ISSN: 0007-0920
  • Volume: 96
  • Issue: 7
  • Pages: 1147-52
  • Medium: Print
  • Language: English
  • Citation (JAMA): Feltbower R G, Kinsey S E, Richards M, et al. Survival Following Relapse in Childhood Haematological Malignancies Diagnosed in 1974-2003 in Yorkshire, Uk.. Br. J. Cancer Apr 2007;96:1147-52

Abstract

We examined population-based information on relapsed childhood haematological cancers, investigating factors that might influence both overall survival and survival following relapse among the 1177 children (0-14 years) diagnosed with a haematological malignancy in Yorkshire from 1974 to 2003, of whom 342 (29%) relapsed at least once. Leukaemia patients from more deprived areas were significantly less likely to relapse (odds ratio=0.54, 95% confidence interval 0.32-0.93 for most deprived quintile vs least deprived quintile; P(trend)=0.06), especially those with acute myeloid leukaemia (P=0.04). Neither ethnic group nor distance to the main treatment centre was associated with risk of relapse. Overall, patients who relapsed at least once had 5-year survival rates of 46% (41-51%) compared with 79% (76-81%) of those who did not. Five-year survival rates from the time of first relapse increased from 20% in 1974-1983 to 45% in 1984-2003. Length of first remission was a strong predictor of survival for leukaemia with a 46% reduced risk of death for every additional year of event-free survival. Of children who experienced a relapse, 46% survived at least 5 years, whereas just under half of patients survived 5 years beyond disease recurrence. This provides a baseline for future comparisons and demonstrates that relapsed childhood cancer need not imply a poor outcome.

Mesh Headings (Keywords): Adolescent, Adult, Child, Child, Preschool, Disease-Free Survival, Great Britain, Hematologic Neoplasms, Humans, Infant, Infant, Newborn, Neoplasm Recurrence, Local, Risk Factors, Survival Rate, Time Factors


Check for Full Text / PubMed Unique Identifier (PMID): 17342086


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.